A Rare STRN-ALK Fusion in Lung Adenocarcinoma Identified Using Next-Generation Sequencing–Based Circulating Tumor DNA Profiling Exhibits Excellent Response to Crizotinib

by Yan Yang, MD, PhD, Shu-Kui Qin, MD, PhD, Jian Zhu, MD, Rui Wang, MD, Yu-Mei Li, MD, Zong-Yu Xie, MD, Qiong Wu, MD, PhD
Published 2017-07-01